Author:
Mayengue Pembe Issamou,Ndounga Mathieu,Malonga Freddy Vladimir,Bitemo Michel,Ntoumi Francine
Abstract
Abstract
Background
The characterization of malaria parasite populations circulating in an area is part of site characterization, as a basis for evaluating the impact of malaria interventions on genetic diversity, parasite species, and multiplicity of infection. The present study was aimed at analysing genetic diversity of Plasmodium falciparum merozoite surface proteins 1 and 2 (MSP-1 and MSP-2) and to determine the multiplicity of infection in clinical isolates collected from children living in the Southern district of Brazzaville in the Republic of Congo.
Methods
A total of 125 isolates from patients with uncomplicated malaria attending Terinkyo and Madibou health centres were collected between January and June 2005 while evaluating the therapeutic efficacy of amodiaquine-artesunate combination. DNA was extracted and msp-1 and msp-2 genes were genotyped using allele-specific nested-PCR.
Results
Out of 468 distinct fragments detected, 15 msp-1 and 20 msp-2 genotypes were identified. For the msp-1 gene, K1 family was the predominant allelic type carried alone or in association with RO33 and Mad20 types, whereas the 3D7 family was the most prevalent in the msp-2 gene. Overall, the mean multiplicity of infection was 2.2. Out of 125 samples, 104 (83%) harboured more than one parasite genotype. There was no statistical significant difference in the multiplicity of infection by either sex or age of patients. However, a statistically significant correlation was found between parasite densities and the number of genotypes.
Conclusion
Polymorphism in P. falciparum clinical isolates from Brazzaville was high and mainly of multiple clones. The basis for the positive association between parasite densities and multiplicity of infection is discussed.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference32 articles.
1. WHO: World malaria report. 2010, [http://www.who.int/malaria/world_malaria_report_2010]
2. Koram KA, Gyan BA: Malaria vaccine development: an endemic country perspective. Hum Vaccin. 2010, 6: 12-16. 10.4161/hv.6.1.9605.
3. Mabiala-Babela JR, Senga P: [Nighttime attendance at the Pediatric Emergency Room of the University Hospital Centre in Brazzaville, Congo](in French). Med Trop. 2009, 69: 281-285.
4. Nsimba B, Malonga DA, Mouata AM, Louya F, Kiori J, Malanda M, Yocka D, Oko-Ossho J, Ebata-Mongo S, Le Bras J: Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo. Am J Trop Med Hyg. 2004, 70: 133-138.
5. Mayengue PI, Ndounga M, Davy MM, Tandou N, Ntoumi F: In vivo chloroquine resistance and prevalence of the pfcrt codon 76 mutation in Plasmodium falciparum isolates from the Republic of Congo. Acta Trop. 2005, 95: 219-225. 10.1016/j.actatropica.2005.06.001.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献